PE20121557A1 - Material probiotico derivado no viable de prevencion y el tratamiento de alergias - Google Patents

Material probiotico derivado no viable de prevencion y el tratamiento de alergias

Info

Publication number
PE20121557A1
PE20121557A1 PE2012000122A PE2012000122A PE20121557A1 PE 20121557 A1 PE20121557 A1 PE 20121557A1 PE 2012000122 A PE2012000122 A PE 2012000122A PE 2012000122 A PE2012000122 A PE 2012000122A PE 20121557 A1 PE20121557 A1 PE 20121557A1
Authority
PE
Peru
Prior art keywords
viable
treatment
probiotic material
allergy prevention
composition
Prior art date
Application number
PE2012000122A
Other languages
English (en)
Spanish (es)
Inventor
Tol Eric A F Van
William Michael Rusell
Udo Herz
Harald Renz
Holger Garn
Machtelt Braaksma
Der Werf Maria Johanna Van
Karin M Overkamp
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of PE20121557A1 publication Critical patent/PE20121557A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/304Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PE2012000122A 2009-09-11 2010-09-10 Material probiotico derivado no viable de prevencion y el tratamiento de alergias PE20121557A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09170124A EP2295535A1 (en) 2009-09-11 2009-09-11 Probiotic material

Publications (1)

Publication Number Publication Date
PE20121557A1 true PE20121557A1 (es) 2012-11-21

Family

ID=41561153

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000122A PE20121557A1 (es) 2009-09-11 2010-09-10 Material probiotico derivado no viable de prevencion y el tratamiento de alergias

Country Status (20)

Country Link
US (1) US20110217402A1 (cg-RX-API-DMAC7.html)
EP (2) EP2295535A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013504321A (cg-RX-API-DMAC7.html)
KR (1) KR20120061836A (cg-RX-API-DMAC7.html)
CN (1) CN102575224A (cg-RX-API-DMAC7.html)
AU (1) AU2010293145B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012005533A2 (cg-RX-API-DMAC7.html)
CA (1) CA2772593C (cg-RX-API-DMAC7.html)
EC (1) ECSP12011786A (cg-RX-API-DMAC7.html)
ES (1) ES2614929T3 (cg-RX-API-DMAC7.html)
IN (1) IN2012DN00951A (cg-RX-API-DMAC7.html)
MX (1) MX345077B (cg-RX-API-DMAC7.html)
MY (1) MY160646A (cg-RX-API-DMAC7.html)
NZ (1) NZ597818A (cg-RX-API-DMAC7.html)
PE (1) PE20121557A1 (cg-RX-API-DMAC7.html)
PL (1) PL2475764T3 (cg-RX-API-DMAC7.html)
RU (1) RU2012114190A (cg-RX-API-DMAC7.html)
SG (1) SG178230A1 (cg-RX-API-DMAC7.html)
TW (1) TWI595090B (cg-RX-API-DMAC7.html)
WO (1) WO2011031149A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130095189A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Composition and method of phytonutrients for metabolic programming effects
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345727B2 (en) * 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) * 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US20150305384A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
MX2016015153A (es) * 2014-05-20 2017-03-07 Biogaia Ab Complementacion de microbioma neonatal.
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
JP7057059B2 (ja) 2016-08-22 2022-04-19 株式会社明治 ラクトバチルス・プランタラムの培養物の製造方法
US20180064739A1 (en) 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180103675A1 (en) 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
US10980269B2 (en) 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
US20180333426A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
AU2018362747B2 (en) * 2017-11-07 2025-08-14 Hubit Genomix, Inc. Method for primary prevention of allergic disorders during infancy through IgE-class-specific immunosuppression
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
EP3524051A1 (en) * 2018-02-12 2019-08-14 DuPont Nutrition Biosciences ApS Matricial microencapsulation compositions
CN119040223B (zh) * 2024-11-01 2025-02-28 微康益生菌(苏州)股份有限公司 一种具有抗炎抗敏功效的鼠李糖乳酪杆菌rh22及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
ZA92452B (en) 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6506389B2 (en) 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
CA2206674A1 (en) * 1996-05-30 1997-11-30 Gregor Reid Lactobacillus therapies
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
WO2000071138A2 (en) * 1999-05-25 2000-11-30 Gregor Reid Oral administration of lactobacillus for the maintenance of health in women
NZ536894A (en) 2000-08-08 2006-04-28 Vialactia Bioscience Nz Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
EP1458247B1 (en) * 2001-12-20 2014-01-22 Biolactis Inc. Malleable protein matrix and uses thereof
EP1572145A1 (en) * 2002-12-13 2005-09-14 L'oreal Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration
US20040208863A1 (en) 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
ATE433674T1 (de) * 2003-06-23 2009-07-15 Nestec Sa Säuglingsnährpräparat oder folgemilch
JP2008501316A (ja) 2004-04-20 2008-01-24 ザ ユニヴァーシティー オヴ シカゴ ラクトバシルスgg由来プロバイオティック化合物及びそれらの使用
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
US20060233772A1 (en) * 2005-04-15 2006-10-19 Udo Herz Method for preventing or treating the development of respiratory allergies
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US9133249B2 (en) * 2006-10-24 2015-09-15 Vanderbilt University Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
JP2010523695A (ja) * 2007-04-11 2010-07-15 アルコン リサーチ, リミテッド アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのTNFαのインヒビターおよび抗ヒスタミン薬の使用
WO2009137159A2 (en) * 2008-04-17 2009-11-12 Trustees Of Dartmouth College Bioactive molecules produced by probiotic bacteria and methods for isolating and using the same

Also Published As

Publication number Publication date
SG178230A1 (en) 2012-03-29
EP2475764B1 (en) 2016-12-14
EP2475764A1 (en) 2012-07-18
ES2614929T3 (es) 2017-06-02
TWI595090B (zh) 2017-08-11
JP2013504321A (ja) 2013-02-07
IN2012DN00951A (cg-RX-API-DMAC7.html) 2015-04-10
US20110217402A1 (en) 2011-09-08
EP2295535A1 (en) 2011-03-16
TW201124529A (en) 2011-07-16
RU2012114190A (ru) 2013-10-20
KR20120061836A (ko) 2012-06-13
ECSP12011786A (es) 2012-07-31
BR112012005533A2 (pt) 2016-04-26
CA2772593C (en) 2018-11-27
CA2772593A1 (en) 2011-03-17
MX2012002716A (es) 2012-04-19
MX345077B (es) 2017-01-16
PL2475764T3 (pl) 2017-06-30
AU2010293145A1 (en) 2012-03-08
AU2010293145B2 (en) 2016-04-14
MY160646A (en) 2017-03-15
CN102575224A (zh) 2012-07-11
WO2011031149A1 (en) 2011-03-17
NZ597818A (en) 2014-01-31

Similar Documents

Publication Publication Date Title
PE20121557A1 (es) Material probiotico derivado no viable de prevencion y el tratamiento de alergias
CL2012002013A1 (es) Microorganismos aislado thrastochytrium sp. atcc pta-10212 util en la produccion de acidos grasos omega-3
AR085943A1 (es) Composicion antimicrobiana
NZ627915A (en) Probiotic derived non-viable material for infection prevention and treatment
PH12016501194A1 (en) Lipid comprising long chain polyunsaturated fatty acids
AR071493A1 (es) Traustoquitridos, composiciones de acidos grasos, y metodos de elaboracion y usos de los mismos
MX2017016283A (es) Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos.
PH12012502437A1 (en) Methods for making animal feed from lignocellulosic biomass
MX335992B (es) Composiciones de grasa solida que contiene un acido graso poliinsaturado y usos y produccion de las mismas.
EA201400151A1 (ru) Микроорганизмы, продуцирующие эйкозапентаеновую кислоту, композиции жирных кислот, способы их получения и применения
AR080615A1 (es) Tratamiento combinado de extracto de tabaco utilizando antioxidantes y barredores de antioxidantes
MX2020003100A (es) Composiciones y metodos para la liofilizacion de bacterias o cepas de listeria.
MX2010004642A (es) Procedimiento para reducir el contenido en acidos grasos saturados de la grasa de leche, productos obtenidos y aplicaciones del mismo.
MX2010005736A (es) Purificacion de materiales grasos tales como aceite.
PH12012501675A1 (en) Method of producing lauric acid-containing oil or fat
GB201121992D0 (en) Process
NZ706877A (en) Hop extract oxidation-reaction product, preparing method thereof and use thereof
MY183775A (en) Concentrated feedstuffs using palm oil byproducts and method for preparing same
IN2014MU02028A (cg-RX-API-DMAC7.html)
BRPI0913122A2 (pt) método para obtenção de óleo enriquecido e óleo enriquecido resultante
WO2012153345A9 (en) Docosahexaenoic acid (dha) as polyunsaturated free fatty acid in its directly compressible powder form and method of isolation thereof
IN2014CN02038A (cg-RX-API-DMAC7.html)
GR1008378B (el) Λειτουργικες επιτραπεζιες ελιες ζυμωμενες με γαλακτικα βακτηρια που διαθετουν προβιοτικες ιδιοτητες
CL2023000858A1 (es) Alimento y composición que comprenden bacterias ácido lácticas y ácido graso
RU2010125576A (ru) Способ получения аутопробиотика, содержащего живые бифидобактерии и лактобациллы

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed